AHRC research grant for investigation into antimicrobial resistance

Posted on 7 July 2017

Pathways, Practices and Architectures will compare the way cystic fibrosis clinics attempt to stop infections from spreading.

Antibiotics may suppress infections without eliminating them, giving rise to antimicrobial-resistant (AMR) bacteria and cross-infection. Our research compares the way three outpatient lung infection clinics attempt to control AMR and cross-infection through the design, practices and architectural layout of their built environments.

Pathways, Practices and Architectures: Containing Antimicrobial Resistance in the Cystic Fibrosis Clinic (PARC) is led by Nik Brown (PI) with Sarah Nettleton, Chrissy Buse, Daryl Martin, Alan Lewis, Lynne Chapman, Mike Brockhurst, Craig Winstanley.

For more details contact nik.brown@york.ac.uk